Press Release - Concept Medical
Press Release

Press Release

  • MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

  • Recurrent multi-metal layer ISR treated with MagicTouch-SCB

  • OCT Follow-Up of Patients Treated for Significant stenosis of mid LAD | Abluminus DES+ | Sirolimus Eluting Stent

  • Vasculogenic Erectile Dysfunction – Case by Prof. Sangiorgi – MagicTouch ED

  • Brand Vision 2020 | The Masterstroke | Republic TV

  • Information given about the use of “Sirolimus Coated Balloon” at Unicare Heart Hospital By Dr. Sandeep Basavaraja and Dr. Dewang Desai.

  • Concept Medical is Granted CE Certification for Sirolimus Coated MagicTouch Group of Products.

  • Getting sued for €25M was the best thing to happen to this award-winning inventor

  • PCI with Novel Sirolimus Eluting Stent

  • Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

  • Concept Medical announces index patient enrolment in world’s first RCT with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease.

  • Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon

  • Concept Medical has created a niche for itself with its innovative drug-coated stent and balloon catheter for diabetic heart patients

  • Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From FDA for Its MagicTouch Sirolimus Coated Balloon.

  • Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

  • Concept Medical Inc. Raises $60mn for Investigational Device Exemption (IDE) for the World’s First Sirolimus-Coated Balloon

  • Do It For Your Heart | World Heart Day 2020

  • Economics Times Rising Indians 2019.

  • Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

  • Founders’ Day 2020


  • LINC 2020: XTOSI study interim findings suggest “highly promising” safety and efficacy of sirolimus DCB

  • The world’s largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start.

  • Sirolimus-eluting balloon is a valid treatment for vasculogenic erectile dysfunction

  • Concept Medical (MagicTouch PTA 0.035 OTW) receives CE Mark for treatment of peripheral artery disease.

  • IVUS guided PCI with MagicTouch SCB

  • MagicTouch Sirolimus Coated Balloon Treatment in LAD with positive remodeling